EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Lipid metabolism reprogramming in cardiac fibrosis

Li-Chan Lin, Zhi-Yan Liu, Jing-Jing Yang, Jian-Yuan Zhao, Hui Tao

Trends in Endocrinology & Metabolism · 2024-02 · 35 (2) · 164-175

DOI: 10.1016/j.tem.2023.10.004 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Trends in Endocrinology & Metabolism, 2024-02. Verfasst von Li-Chan Lin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology and Perioperative Medicine, The Second Affiliated Hospital of Anhui Medical University, Hefei, 230601, China. Hauptthemen laut MEDLINE: Myocardium, Cardiomyopathies. Die Arbeit wurde bisher 56-mal zitiert (Crossref) und nennt 103 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cardiac fibrosis is a critical pathophysiological process that occurs with diverse types of cardiac injury. Lipids are the most important bioenergy substrates for maintaining optimal heart performance and act as second messengers to transduce signals within cardiac cells. However, lipid metabolism reprogramming is a double-edged sword in the regulation of cardiomyocyte homeostasis and heart function. Moreover, lipids can exert diverse effects on cardiac fibrosis through different signaling pathways. In this review, we provide a brief overview of aberrant cardiac lipid metabolism and recent progress in pharmacological research targeting lipid metabolism alterations in cardiac fibrosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MyocardiumCardiomyopathiesHumansLipid MetabolismMetabolic ReprogrammingMyocytes, CardiacFibrosisLipids

Stichwörter der Autor:innen

cardiac fibrosisepigeneticferroptosislipid metabolism

Substanzen

Lipids

Autor:innen und Institutionen

  • Department of Anesthesiology and Perioperative Medicine, The Second Affiliated Hospital of Anhui Medical University, Hefei, 230601, China.
  • Department of Clinical Pharmacology, The Second Affiliated Hospital of Anhui Medical University, Hefei, 230601, China. Electronic address: yangjingjing@ahmu.edu.cn.
  • Institute for Developmental and Regenerative Cardiovascular Medicine, MOE-Shanghai Key Laboratory of Children's Environmental Health, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200092,…
  • Department of Anesthesiology and Perioperative Medicine, The Second Affiliated Hospital of Anhui Medical University, Hefei, 230601, China; Department of Cardiothoracic Surgery, The Second Affiliated Hospital of Anhui Me…

Zitieren

APA

Lin, L. C., Liu, Z. Y., Yang, J. J., Zhao, J. Y., & Tao, H. (2024). Lipid metabolism reprogramming in cardiac fibrosis. Trends in Endocrinology & Metabolism, 35(2), 164-175. https://doi.org/10.1016/j.tem.2023.10.004

Vancouver

Lin LC, Liu ZY, Yang JJ, Zhao JY, Tao H. Lipid metabolism reprogramming in cardiac fibrosis. Trends in Endocrinology & Metabolism. 2024;35(2):164-175. doi:10.1016/j.tem.2023.10.004

BibTeX
@article{Lin2024,
  author = {Lin, Li-Chan and Liu, Zhi-Yan and Yang, Jing-Jing and Zhao, Jian-Yuan and Tao, Hui},
  title = {Lipid metabolism reprogramming in cardiac fibrosis},
  journal = {Trends in Endocrinology & Metabolism},
  year = {2024},
  volume = {35},
  number = {2},
  pages = {164--175},
  doi = {10.1016/j.tem.2023.10.004}
}
Kostenlos starten →